# Regenicin, Inc.

Regenicin, Inc. is a company headquartered in Las Vegas, NV, United States.

## Company overview

- **Legal name:** Regenicin, Inc.
- **Former names in filing history:** Windstar Inc. (2007-10-22 to 2010-07-15)
- **Classification:** Company
- **Industry (SIC):** 3841 — Surgical & Medical Instruments & Apparatus
- **Headquarters:** Las Vegas, NV, United States
- **Incorporated in:** NV
- **Fiscal year end:** September 30
- **SEC CIK:** 0001412659

## About

Regenicin, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001412659, and its reported industry is Surgical & Medical Instruments & Apparatus. In 10-K filed on 2022-01-13, it reported net income of USD -877,102; total assets of USD 4,609 for the fiscal period ended 2021-09-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2021 (period ended 2021-09-30)

- **Net income:** -$877,102 (USD -877,102)
- **Total assets:** $4,609 (USD 4,609)
- **Operating cash flow:** -$24,107 (USD -24,107)
- **Later filings:** Net income, Total assets, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2020 (period ended 2020-09-30)

- **Net income:** $559,591 (USD 559,591)
- **Total assets:** $4,141 (USD 4,141)
- **Cash and equivalents:** $1,366 (USD 1,366)
- **Operating cash flow:** -$123,199 (USD -123,199)
- **Later filings:** Net income, Total assets, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2019 (period ended 2019-09-30)

- **Net income:** $758,456 (USD 758,456)
- **Total assets:** $5,315 (USD 5,315)
- **Cash and equivalents:** $815 (USD 815)
- **Operating cash flow:** -$126,862 (USD -126,862)
- **Later filings:** Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2018 (period ended 2018-09-30)

- **Net income:** -$559,058 (USD -559,058)
- **Total assets:** $56,433 (USD 56,433)
- **Cash and equivalents:** $2,702 (USD 2,702)
- **Operating cash flow:** -$133,721 (USD -133,721)
- **Later filings:** Net income, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2024-12-23 — period 2024-12-20 — 8-K
- Form 8-K — filed 2024-11-12 — period 2024-11-05 — 8-K
- Form 8-K — filed 2024-11-06 — period 2024-10-31 — 8-K
- Form 8-K — filed 2023-09-14 — period 2023-06-12 — 8-K
- Form 10-Q — filed 2023-05-15 — period 2023-03-31 — 10-Q
- Form 10-Q — filed 2023-02-13 — period 2022-12-31 — 10-Q
- Form 10-K — filed 2023-01-13 — period 2022-09-30 — 10-K
- Form 10-Q — filed 2022-08-12 — period 2022-06-30 — 10-Q
- Form 10-Q — filed 2022-05-23 — period 2022-03-31 — 10-Q
- Form 10-K/A — filed 2022-03-25 — period 2021-09-30 — 10-K/A
- Form SC 13G — filed 2022-03-17
- Form 10-Q — filed 2022-02-14 — period 2021-12-31 — 10-Q

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/regenicin-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology